Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Large-scale testing (Phase 3)Ended earlyNCT03870763
What this trial is testing

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 11
Not applicableStudy completedNCT04858763
What this trial is testing

MS Relapses During COVID-19 Pandemic

Who this might be right for
Multiple SclerosisCovid19Relapsing Remitting Multiple Sclerosis
Nottingham University Hospitals NHS Trust 51
Testing effectiveness (Phase 2)Study completedNCT00882999
What this trial is testing

Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Eli Lilly and Company 245
Not applicableActive Not RecruitingNCT05811416
What this trial is testing

Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Bristol-Myers Squibb 200
Not applicableUnknownNCT03508414
What this trial is testing

Nutritional Approaches in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 111
Large-scale testing (Phase 3)Study completedNCT02792231
What this trial is testing

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Relapsing Multiple Scelrosis
Novartis Pharmaceuticals 955
Large-scale testing (Phase 3)Ended earlyNCT04140305
What this trial is testing

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

Who this might be right for
Multiple Sclerosis
Celgene 188
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Not applicableUnknownNCT06303024
What this trial is testing

Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Fondazione Don Carlo Gnocchi ETS 140
Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Study completedNCT01450124
What this trial is testing

Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 29
Not applicableStudy completedNCT02010554
What this trial is testing

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 40
Not applicableStudy completedNCT05423769
What this trial is testing

Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hikma Pharmaceuticals LLC 30
Not applicableStudy completedNCT01881191
What this trial is testing

Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 50
Not applicableActive Not RecruitingNCT07497126
What this trial is testing

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Malnutrition or Risk of Malnutrition
Antalya Training and Research Hospital 169
Large-scale testing (Phase 3)Study completedNCT01433497
What this trial is testing

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free
AB Science 656
Not applicableNot Yet RecruitingNCT07827586
What this trial is testing

Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche 1,800
Large-scale testing (Phase 3)WithdrawnNCT00429442
What this trial is testing

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Anna Tsakiri
Next Page